DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹5,655 Cr | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹5,655 Cr |
| Mar2025 | ₹5,578 Cr |
| Mar2024 | ₹4,507 Cr |
| Mar2023 | ₹2,183 Cr |
| Mar2022 | ₹1,952 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,655 Cr | 1.38 | |
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | - | |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹102,709.8 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| MANKIND PHARMA | ₹99,089.5 Cr | -3.5% | 5.9% | -3.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.8% |
7.6% |
-4.3% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses